Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Strainprint Technologies is a leading medical cannabis data and analytics company that provides a platform for patients to track their medication use and outcomes. The company's mobile app allows users to log their symptoms, the specific cannabis strains or products used, and the resulting efficacy in real-time. This crowdsourced, longitudinal data is then anonymized and analyzed to provide insights for clinicians, researchers, and industry stakeholders. By bridging the gap between patient experience and clinical evidence, Strainprint aims to optimize cannabis-based therapies and improve patient outcomes globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Strainprint Technologies.